Search results
Results From The WOW.Com Content Network
Secukinumab was discovered and developed by Novartis using developmental name AIN457, and the first publication was a Phase I trial published in 2010. In January 2015, secukinumab was approved in the United States and in the European Union to treat adults with moderate-to-severe plaque psoriasis.
Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, used for the treatment of multiple sclerosis. Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction.
This is the actual form of the drug sold as Gleevec/Glivec; a salt (imatinib mesylate) as opposed to a free base, and the beta crystalline form as opposed to the alpha or other form.: 3 and 4 In 1998, Novartis filed international patent applications claiming priority to the 1997 filing. A United States patent was granted in 2005.
The cost of the surgery can be significant. According to ASPS, the average cost of a surgeon’s fee for cosmetic breast reduction is $6,771. Additional fees may include anesthesia and hospital or ...
Kevin Jonas has revealed he has undergone surgery to remove a cancerous mole from his forehead. Jonas, 36, shared his experience online on Tuesday, June 11, in an effort to heighten vigilance ...
Nilotinib. Nilotinib, sold under the brand name Tasigna marketed worldwide by Novartis, is a medication used to treat chronic myelogenous leukemia (CML) which has the Philadelphia chromosome. [4] It may be used both in initial cases of chronic phase CML as well as in accelerated and chronic phase CML that has not responded to imatinib.
Medical uses. Siponimod is indicated for the treatment of secondary progressive multiple sclerosis, which is the progressive neurological decline of multiple sclerosis that happens independent of acute relapses. In active secondary progressive multiple sclerosis, siponimod decreases the risk of disability and multiple sclerosis relapses.
The main discussion of these abbreviations in the context of drug prescriptions and other medical prescriptions is at List of abbreviations used in medical prescriptions. Some of these abbreviations are best not used, as marked and explained here.